Treatment of primary and metastatic carcinoma

• 收藏
• 分享

专利权人:

Spectrum Pharmaceuticals Inc.

发明人:

Anthony W. Tolcher,Luigi Lenaz

申请号：

US15061821

公开号：

US10022421B2

申请日:

2016.03.04

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Disclosed are methods of treating a chemotherapy-resistant cancer, of treating a cholangiocarcinoma, of treating a metastatic carcinoma, and of treating a transition cell urothelial carcinoma by administering a therapeutically effective amount of an endothelin B (ETB) receptor agonist and a chemotherapeutic agent to a subject afflicted with such a cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/